ABBVIE INC.
$262.51
-$0.53 (-0.20%)
$260.98Day Range$264.00
Key Statistics
Market Cap
$463.89B
Shares Outstanding
1,767.1M
Primary Exchange
XNYS
Currency
USD
Type
CS
IPO Date
Dec 10, 2012
Round Lot
100
Locale
US
Trading Data
Day Open
$261.99
Day High
$264.00
Day Low
$260.98
Volume
3.12M
VWAP
$262.59
Prev Close
$263.04
Transactions
--
Acc. Volume
--
About ABBVIE INC.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
PHARMACEUTICAL PREPARATIONSSIC 283457,000 employees1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, 60064(847) 932-7900IPO Dec 10, 2012US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001551152
- Composite FIGI
- BBG0025Y4RY4
- Share Class FIGI
- BBG0025Y4RZ3
- Ticker Root
- ABBV
- SIC Code
- 2834
About ABBVIE INC. (ABBV) Stock
ABBVIE INC. (ABBV) closed the 2026-09-16 session at $262.51, down 0.20% versus the previous close (-0.53). The stock opened at $261.99 and traded between $260.98 and $264.00 during that session. Session trading volume was 3.1M shares. The volume-weighted average price (VWAP) is $262.59.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
ABBVIE INC. has a market capitalization of $463.89 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. ABBV is listed on the XNYS exchange. The company employs approximately 57,000 people. ABBVIE INC. is headquartered in NORTH CHICAGO, IL. The recorded listing date is 2012-12-10.
On this page you can find market ABBV stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.